Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

NCT02584959 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema (HAE)

Interventions

DRUG: C1 esterase inhibitor [human] liquid
DRUG: Placebo

Sponsor

Shire